( Bloomberg:460@HK, HongKong:0460 )

News from Sihuan Pharmaceutical Holdings Group Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

27 Aug, 2014, 10:04 ET Sihuan Pharmaceutical Announces 2014 Interim Results

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


10 Oct, 2013, 09:02 ET CFDA Accepts Sihuan Pharmaceutical's Application for Clinical Trial Approval for Self-Developed Innovative Oncology Drug Pirotinib

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


26 Aug, 2013, 06:39 ET Sihuan Pharmaceutical Announces 2013 Interim Results

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical...


17 Jul, 2013, 12:36 ET Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


25 Mar, 2013, 03:24 ET Sihuan Pharmaceutical Announces 2012 Annual Results

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


22 Feb, 2013, 06:26 ET State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with...


22 Jan, 2013, 08:45 ET State Food and Drug Administration Grants Approval for Clinical Studies to Sihuan Pharmaceutical's Innovative Drug -- Benapenem

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


16 Jan, 2013, 07:18 ET Sihuan's Generic Drug Nalmefene Hydrochloride Receives Approval for Pharmaceutical Registration from State Food and Drug Administration

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


20 Nov, 2012, 07:58 ET Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with...


31 Oct, 2012, 06:09 ET Sihuan's First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


30 Aug, 2012, 21:35 ET Sihuan Pharmaceutical Announces 2012 Interim Results

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


25 May, 2012, 08:00 ET Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


19 Mar, 2012, 08:43 ET Sihuan Pharmaceutical Announces 2011 Annual Results

Sihuan  Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


11 Mar, 2012, 05:00 ET Sihuan Pharmaceutical Achieves Important R&D Breakthrough

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company and...


17 Nov, 2010, 20:03 ET Sihuan Pharmaceutical Obtains 30-Year Exclusive Distribution Rights for One of the Best Selling Cardio-Cerebral Vascular Drugs in China

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise...